sparfloxacin has been researched along with Neutropenia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iwagaki, A; Matsumoto, K; Nagatake, T; Oishi, K; Pollack, M; Ponglertnapagorn, P; Siadak, A; Sonoda, F; Watanabe, K | 1 |
Iwagaki, A; Kobayashi, S; Matsumoto, K; Nagatake, T; Oishi, K; Sonoda, F | 1 |
2 other study(ies) available for sparfloxacin and Neutropenia
Article | Year |
---|---|
Therapeutic effects of a human antiflagella monoclonal antibody in a neutropenic murine model of Pseudomonas aeruginosa pneumonia.
Topics: Animals; Anti-Infective Agents; Antibodies, Monoclonal; Bacteremia; Cell Movement; Female; Flagella; Fluoroquinolones; Humans; Lipopolysaccharides; Lung; Mice; Mice, Inbred ICR; Neutropenia; Opsonin Proteins; Phagocytosis; Pneumonia; Pseudomonas Infections; Quinolones; Serotyping | 1993 |
Effects of the combination of lipopolysaccharide-specific monoclonal antibodies and sparfloxacin against Pseudomonas aeruginosa pneumonia in neutropenic mice.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Antibodies, Monoclonal; Cyclophosphamide; Drug Therapy, Combination; Female; Fluoroquinolones; Immunoglobulin G; Injections, Intravenous; Lipopolysaccharides; Lung; Mice; Mice, Inbred ICR; Neutropenia; Pneumonia; Pseudomonas Infections; Quinolones | 1992 |